Glenmark launches coronavirus medicine

New Delhi. The whole world is troubled by the Wuhan virus i.e. Corona epidemic, but now its medicine has been launched in India. The Corana epidemic was launched by Glenmark Pharmaceuticals on Saturday. According to the company, the drug has been launched to treat patients with corona virus moderately infected. This drug is Fabiflu to the antiviral drug Favipiravir. The Mumbai-based company on Friday received approval from the Drugs Controller General of India to manufacture and sell the drug.coronavirus medicine at ₹103 per tabletKnow what the company said

Glenmark Pharmaceuticals has stated that Fabifu Corana, the Favipiravir, is the first drug to be used for covid-19 treatment. It has been approved. According to the company’s chairman and managing director Glenn Saldanha, this drug has come at a time when the number of corona virus infected patients is increasing in India more rapidly than before. Due to this our health care system is under great pressure. He hoped that the availability of effective treatment like Fabiflu would help reduce this pressure to a great extent.

This medicine is to be eaten

Glenmark Pharmaceuticals chairman and managing director Glenn Saldanha has said that in clinical trials Fabiflu gave better results in moderately corona-infected patients. He said that this medicine is a food, so it is a better option for treatment.

Will work together with the government

Glenn Saldanha, chairman and managing director of Glenmark Pharmaceuticals, said it would work closely with the company and the government to easily provide the drug to Corona-infected patients across the country. The company has asked to eat this medicine based on the advice of the doctor.

Know the price of medicine and its dosage

The price of this medicine is Rs 103 per tablet. 1800mg dose of this medicine should be taken 2 times on the first day. After this, 800 mg medicine should be taken twice a day for 14 days. This medicine can also be given to people suffering from diabetes and heart disease. The drug company said that with this medicine, improvement of corona virus infected patients starts in 4 days. It begins to rapidly improve symptoms and radiologically.

Also Read – COVID-19: More than 55 percent patients infected with corona in the country got discharged from hospitals